Expression of T-Lymphocyte Markers in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer

Por Lee, Changro, Park, Seho, Kim, Joo Heung, Lim, Sung Mook, Park, Hyung Seok, Kim, Seung Il, Park, Byeong-Woo
Publicado no J Breast Cancer (2016)

PEG-transferrin conjugated TRAIL (TNF-related apoptosis-inducing ligand) for therapeutic tumor targeting

Por Kim, Tae Hyung, Jo, Young Gi, Jiang, Hai Hua, Lim, Sung Mook, Youn, Yu Seok, Lee, Seulki, Chen, Xiaoyuan, Byun, Youngro, Lee, Kang Choon
Publicado em 2012

Delivery of tumor-homing TRAIL sensitizer with long-acting TRAIL as a therapy for TRAIL-resistant tumors

Por Oh, Yumin, Swierczewska, Magdalena, Kim, Tae Hyung, Lim, Sung Mook, Eom, Ha Na, Park, Jae Hyung, Na, Dong Hee, Kim, Kwangmeyung, Lee, Kang Choon, Pomper, Martin G., Lee, Seulki
Publicado no J Control Release (2015)

Systemic PEGylated TRAIL treatment ameliorates liver cirrhosis in rats by eliminating activated hepatic stellate cells

Por Oh, Yumin, Park, Ogyi, Swierczewska, Magdalena, Hamilton, James P., Park, Jong-Sung, Kim, Tae Hyung, Lim, Sung-Mook, Eom, Hana, Jo, Dong Gyu, Lee, Choong-Eun, Kechrid, Raouf, Mastorakos, Panagiotis, Zhang, Clark, Hahn, Sei Kwang, Jeon, Ok-Cheol, Byun, Youngro, Kim, Kwangmeyung, Hanes, Justin, Lee, Kang Choon, Pomper, Martin G., Gao, Bin, Lee, Seulki
Publicado no Hepatology (2016)